Evidence map›Paper›PMID 40671917›Full record

ReviewMicroplastics and nanoplastics2025

Exposure scenarios for human health risk assessment of nano- and microplastic particles.

Taylor Lane, Ira Wardani, Albert A Koelmans

Abstract readReview
In one paragraph

Review in Microplastics and nanoplastics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Nanoplastics and Neurodegeneration: A Roadmap From Mechanism to Causation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Taylor LaneAquatic Ecology and Water Quality Management Group, Department of Environmental Sciences, Wageningen University, Wageningen, 6700 AA The Netherlands.
Ira WardaniAquatic Ecology and Water Quality Management Group, Department of Environmental Sciences, Wageningen University, Wageningen, 6700 AA The Netherlands.
Albert A KoelmansAquatic Ecology and Water Quality Management Group, Department of Environmental Sciences, Wageningen University, Wageningen, 6700 AA The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evidence of nano- and microplastic particles being present in the human body has increased in recent years, yet there is no acceptable methodology to perform a human health risk assessment for these particles because of limitations in the exposure and hazard assessments. Exposure assessment can be improved by establishing comprehensive and justifiable exposure scenarios for a defined exposure demographic, thoroughly describing the relevant exposure pathways, and performing multidimensional data alignment, thereby facilitating probabilistic estimates of nano- and microplastic particle exposure. General considerations of exposure scenarios are outlined, along with specifics details on the complexity and prioritization for nine demographic groups: adults; women; the elderly; individuals with disease; individuals employed in high-hazard occupations; and children demographics, including early infants, toddlers, school children, and teenagers. Recommendations to advance exposure assessments and scenarios are also provided which suggest: i) the use of well-defined exposure scenarios for demographics that are prioritized according to their level of complexity and concern; ii) a thorough description of relevant activity factors (physiological parameters, behavioural traits) and exposure factors (duration, frequency, media characterization) for the chosen demographic; iii) thorough descriptions of exposure via ingestion and inhalation, and in the case of early infants, including exposure via maternal transfer; iv) multidimensional data alignment and probabilistic methods to enable credible comparisons of exposure data across studies and inform physiologically based toxicokinetic models to estimate internal exposure. Supplementary Information: The online version contains supplementary material available at 10.1186/s43591-025-00134-9.

Indexed as

Data alignmentDemographic assessmentExposure pathwaysMicroplastic

Identifiers

PMID40671917
PMCPMC12259766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.